From Metabolic Syndrome To Cachexia: What’S New About Metabolic Biomarkers ?
Written by Odile Viltart and Virginie Tolle, PhD – INSERM UMR894 – Centre de Psychiatrie et Neurosciences, Paris, FRANCE Metabolic syndrome (MetS) is the constellation
Written by Odile Viltart and Virginie Tolle, PhD – INSERM UMR894 – Centre de Psychiatrie et Neurosciences, Paris, FRANCE Metabolic syndrome (MetS) is the constellation
From June 19th to 21st, meet our experts in Ferrara, Italy, at the annual meeting of the society for free radical research From June 19th
From May 22nd to 24th, meet our experts at @ESPHM (European Symposium of Porcine Health Management) for its 11th edition, which is taking place in
Inflammation is a critical, signal-mediated response to potential signs of danger and damage… Inflammation is a critical, signal-mediated response to potential signs of danger and damage.
AFERO 35th annual scientific meeting will take place in Marseille on January 31st and February 1st 2019. Meet us at Afero Annual Scientific Days AFERO
Insulin is a key player in glucose homeostasis and its quantification is essential in metabolism studies. What is insulin? Insulin is produced by the beta
Bertin Bioreagents innovations displayed at the EUROTOX Congress 2018 | September 2-5, Brussels, Belgium According to intergovernmental organizations, “An endocrine disruptor is an exogenous substance
Meet our Bioreagent experts at the SFRRI biennal meeting | June 4-7, Lisbon Meet Bertin Bioreagent team Booth #10, at the Lisbon Conference Centre during the 19th
Cytokines are small molecules playing a central role in intracellular signaling connected to immunity and defense… Cytokines are small molecules playing a central role in
Odile Viltart & Virginie Tolle, PhD, from the Psychiatry & Neurosciences Center in Paris, validated Bertin Bioreagent’s immunoassay kits by demonstrating the absence of immunoreactivity
Bertin Pharma is acquired by Bertin Technologies on January 2018. The Bioreagent activity is now included into the Business Unit Systems & Instrumentation. Bertin Technologies
On August 2017, Bertin Pharma has signed an agreement for the sale of its pre-clinical and clinical studies’ activities. Bertin Pharma decided to focus on
Headquarters:
Parc d’activités du Pas du Lac
10 bis avenue Ampère
78180 Montigny le Bretonneux
France
Copyright © 2024 BERTIN BIOREAGENT. All rights reserved | Terms & conditions